Finally some strength in the mid-sized group with GeoVax and CureVac whacked

A late afternoon bounce back by many mid-sized Covid Vaccine Stocks resulted in a gain overall with a pick up of 1.1%.

Weaklings of 2022, Aructurus, VBI and Immunity Bio, picked up 7% today.  Altimmune, Ocugen and Emergent picked up 6%. The three big boys all slipped again today with Novavax reaching all the way down to $110--losing half its value since Christmas.

There were 15 gainers with 11 losers. 

There were two particular losers: GeoVax down 11.5% and CureVac lost just under 10%.